A number of promising antiplatelet therapies currently in advanced clinical testing offer hope for improving cardiovascular outcomes in patients with acute coronary syndromes and those undergoing percutaneous interventions. We review the preclinical pharmacology and selected ongoing clinical trials of promising novel platelet inhibitor therapies. © 2008 Mosby, Inc. All rights reserved.
Pharmacology of emerging novel platelet inhibitors
Capranzano, PieraWriting – Original Draft Preparation
2008-01-01
Abstract
A number of promising antiplatelet therapies currently in advanced clinical testing offer hope for improving cardiovascular outcomes in patients with acute coronary syndromes and those undergoing percutaneous interventions. We review the preclinical pharmacology and selected ongoing clinical trials of promising novel platelet inhibitor therapies. © 2008 Mosby, Inc. All rights reserved.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Pharmacology of emerging novel platelet inhibitors.pdf
solo gestori archivio
Tipologia:
Versione Editoriale (PDF)
Licenza:
NON PUBBLICO - Accesso privato/ristretto
Dimensione
389.5 kB
Formato
Adobe PDF
|
389.5 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
